Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The Nice Manifesto

27.03.2006


Almost 5,000 delegates at the 5th European Breast Cancer Conference (EBCC-5) today attended the presentation of the Nice Manifesto. The manifesto represents a commitment from doctors, nurses, patients and advocates to support breast cancer research and improve patient care. Breast Cancer is the most common cancer in European women and although survival rates are improving there is still a long way to go.



The manifesto is endorsed by the three organisations – Europa Donna – The European Breast Cancer Coalition, The European Organisation for Research and Treatment of Cancer (EORTC) and the European Society of Mastology (EUSOMA) who hosted the event. This conference is the only one of its kind as it represents the views of all the major breast cancer advocacy groups and institutions in one arena. This manifesto is a unique document that represents the concerns of all those involved in breast cancer treatment, from the patient to the oncologist.

Dr A. Costa, the chair of the European Breast Cancer Conference, and Dr S. Kyriakides, co-chair stated, “Europe is now 500 million strong, more than half of these are women, and at least one in ten will experience breast cancer. This is a major public health priority. The Nice manifesto is a promise to improve breast cancer care for all those patients across Europe. It is a basic right for patients to expect the best care and the conference pledges to meet the challenge.”


The following seven goals form the basis of the manifesto:

1. Improve the number and quality of European screening programmes
Population based screening programmes carried out in accordance with EU guidelines for quality assurance in mammography screening help to detect early breast cancer and save lives. Increasing the number of screening programmes free at the point of access and improving their quality would save the lives of many European women. Women should be encouraged to participate in screening programmes.

2. Support breast cancer research
Independent academic research is under threat due to insufficient funding in many European countries. It is a driving force in improving our knowledge of cancer and developing tailored, potentially cost-saving therapies. Studies which answer important clinical questions and which have the potential to increase our knowledge of the biological and genetic basis of the disease should be given priority.

3. Rethink the breast cancer staging system
Researchers and clinicians should be creative in designing new quality assured diagnostic and staging systems which improve prediction of outcome. The genetic makeup of the tumour, for instance, should be defined in greater detail to identify the natural history of the disease in each individual patient, and the likelihood of response to standard therapies and molecular targeted treatments.

4. Define metastatic breast cancer guidelines
Most women still die from metastatic breast cancer. The general criteria on how to manage metastatic breast cancer need to be defined. Specific guidelines can help the patient and the clinician make the right choice.

5. Increase the number of breast care nurses
In most European countries today there are no breast care nurses. Breast care nurses can improve the treatment and management of breast cancer for patients. Greater involvement will improve patient care and quality of life.

6. Expand the Breast Unit accreditation process
Breast units should be accredited to ensure that they meet guideline requirements for standardisation of best care. Accreditation guidelines for carrying this out should be developed not only by professionals, but also by patient advocacy groups. Women should have equity of access and the choice to select appropriate facilities for diagnosis and treatment and be sure they are getting gold standard.

7. Give recognition to the essential role played by charities in independent breast cancer research
Encourage those charities to realise the potential benefits of their effort for all European patients and to expand their work even further.

EBCC-5 Press Office | alfa
Further information:
http://www.fecs.be/emc.asp?pageId=611&Type=P

More articles from Health and Medicine:

nachricht Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>